PL380437A1 - Antagonistyczne analogi GH-RH (2003) - Google Patents
Antagonistyczne analogi GH-RH (2003)Info
- Publication number
- PL380437A1 PL380437A1 PL380437A PL38043704A PL380437A1 PL 380437 A1 PL380437 A1 PL 380437A1 PL 380437 A PL380437 A PL 380437A PL 38043704 A PL38043704 A PL 38043704A PL 380437 A1 PL380437 A1 PL 380437A1
- Authority
- PL
- Poland
- Prior art keywords
- antagonistic analogs
- antagonistic
- analogs
- Prior art date
Links
- 230000003042 antagnostic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49270603P | 2003-08-05 | 2003-08-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL380437A1 true PL380437A1 (pl) | 2007-01-22 |
Family
ID=34193144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL380437A PL380437A1 (pl) | 2003-08-05 | 2004-07-26 | Antagonistyczne analogi GH-RH (2003) |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7452865B2 (pl) |
| EP (1) | EP1651662A4 (pl) |
| JP (1) | JP2007526900A (pl) |
| KR (1) | KR20060088875A (pl) |
| CN (1) | CN1871020A (pl) |
| AR (1) | AR049149A1 (pl) |
| AU (1) | AU2004265280A1 (pl) |
| BR (1) | BRPI0413257A (pl) |
| CA (1) | CA2534436A1 (pl) |
| IL (1) | IL173201A0 (pl) |
| MX (1) | MXPA06001369A (pl) |
| NO (1) | NO20061060L (pl) |
| PL (1) | PL380437A1 (pl) |
| RS (1) | RS20060086A (pl) |
| RU (1) | RU2335506C2 (pl) |
| SG (1) | SG136958A1 (pl) |
| TW (1) | TW200517400A (pl) |
| WO (1) | WO2005016953A2 (pl) |
| ZA (1) | ZA200600966B (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009108364A2 (en) * | 2008-02-27 | 2009-09-03 | Ipsen Pharma S.A.S. | Antagonistic analogues of ghrh |
| US8691942B2 (en) | 2008-03-28 | 2014-04-08 | University Of Miami | N- and C- terminal substituted antagonistic analogs of GH-RH |
| MX2010010642A (es) * | 2008-03-28 | 2011-03-29 | The Univ Of Miami | Nuevos analogos antagonistas, sustituidos, n- y c- terminales, de hormona liberadora de hormona de crecimiento (gh-rh). |
| US20110171191A1 (en) * | 2008-06-12 | 2011-07-14 | Syntaxin Limited | Suppression of neuroendocrine diseases |
| US10240138B2 (en) | 2008-06-12 | 2019-03-26 | Ipsen Bioinnovation Limited | Polypeptides that bind to and inhibit secretion from growth hormone secreting cells |
| US8796216B2 (en) | 2008-06-12 | 2014-08-05 | Syntaxin Limited | Suppression of neuroendocrine diseases |
| US8227421B2 (en) | 2009-09-17 | 2012-07-24 | University Of Miami | Fluorinated GHRH antagonists |
| WO2011153491A2 (en) | 2010-06-03 | 2011-12-08 | University Of Miami | Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets |
| JP6113144B2 (ja) | 2011-04-21 | 2017-04-12 | セラテクノロジーズ・インコーポレーテッド | 成長ホルモン放出因子（ｇｒｆ）類似体およびその使用 |
| US9079974B2 (en) | 2011-12-21 | 2015-07-14 | The University Of Miami | GH-RH analogs with potent agonistic effects |
| US20150166617A1 (en) * | 2012-06-27 | 2015-06-18 | University Of Miami | Compositions and methods of treating alzheimer's disease |
| WO2014100809A2 (en) | 2012-12-21 | 2014-06-26 | University Of Miami | Ghrh agonists for the treatment of ischemic disorders |
| EP2935317B1 (en) | 2012-12-21 | 2019-03-27 | University of Miami | Ghrh agonists for islet cell transplantation and function and the treatment of diabetes |
| AU2020218272A1 (en) | 2019-02-08 | 2021-09-02 | United States Government As Represented By The Department Of Veterans Affairs | Growth hormone-releasing hormone antagonists and uses thereof |
| CA3178840A1 (en) | 2020-04-27 | 2021-11-04 | The University Of Miami | Method of treating an inflammatory disorder |
| CN114195881B (zh) * | 2021-12-16 | 2022-09-16 | 浙江湃肽生物股份有限公司 | 一种制备醋酸舍莫瑞林的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5942489A (en) * | 1996-05-03 | 1999-08-24 | The Administrators Of The Tulane Educational Fund | HGH-RH(1-29)NH2 analogues having antagonistic activity |
| US6057422A (en) * | 1998-11-25 | 2000-05-02 | The Administrators Of The Tulane Educational Fund | Antagonistic analogs of GH-RH inhibiting IGF-I and -II |
-
2004
- 2004-07-23 TW TW093121985A patent/TW200517400A/zh unknown
- 2004-07-26 RS YUP-2006/0086A patent/RS20060086A/sr unknown
- 2004-07-26 EP EP04757325A patent/EP1651662A4/en not_active Withdrawn
- 2004-07-26 RU RU2006106701/04A patent/RU2335506C2/ru not_active IP Right Cessation
- 2004-07-26 JP JP2006522602A patent/JP2007526900A/ja active Pending
- 2004-07-26 MX MXPA06001369A patent/MXPA06001369A/es unknown
- 2004-07-26 CN CNA2004800222868A patent/CN1871020A/zh active Pending
- 2004-07-26 PL PL380437A patent/PL380437A1/pl unknown
- 2004-07-26 WO PCT/US2004/024183 patent/WO2005016953A2/en active Application Filing
- 2004-07-26 US US10/566,776 patent/US7452865B2/en not_active Expired - Fee Related
- 2004-07-26 KR KR1020067002465A patent/KR20060088875A/ko active IP Right Grant
- 2004-07-26 BR BRPI0413257-2A patent/BRPI0413257A/pt not_active IP Right Cessation
- 2004-07-26 SG SG200716961-8A patent/SG136958A1/en unknown
- 2004-07-26 CA CA002534436A patent/CA2534436A1/en not_active Abandoned
- 2004-07-26 AU AU2004265280A patent/AU2004265280A1/en not_active Abandoned
- 2004-08-03 AR ARP040102755A patent/AR049149A1/es unknown
-
2006
- 2006-01-17 IL IL173201A patent/IL173201A0/en unknown
- 2006-02-02 ZA ZA200600966A patent/ZA200600966B/en unknown
- 2006-03-03 NO NO20061060A patent/NO20061060L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007526900A (ja) | 2007-09-20 |
| US20070042950A1 (en) | 2007-02-22 |
| WO2005016953A2 (en) | 2005-02-24 |
| CA2534436A1 (en) | 2005-02-24 |
| TW200517400A (en) | 2005-06-01 |
| RS20060086A (en) | 2008-08-07 |
| US7452865B2 (en) | 2008-11-18 |
| KR20060088875A (ko) | 2006-08-07 |
| SG136958A1 (en) | 2007-11-29 |
| WO2005016953A3 (en) | 2006-02-09 |
| RU2006106701A (ru) | 2007-09-20 |
| AR049149A1 (es) | 2006-07-05 |
| NO20061060L (no) | 2006-05-03 |
| CN1871020A (zh) | 2006-11-29 |
| EP1651662A2 (en) | 2006-05-03 |
| AU2004265280A1 (en) | 2005-02-24 |
| ZA200600966B (en) | 2007-05-30 |
| EP1651662A4 (en) | 2009-07-01 |
| RU2335506C2 (ru) | 2008-10-10 |
| BRPI0413257A (pt) | 2006-10-03 |
| IL173201A0 (en) | 2006-06-11 |
| MXPA06001369A (es) | 2007-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL173201A0 (en) | Antagonistic analogs of gh-rh (2003) | |
| PL367260A1 (pl) | Preparat do pozajelitowego podawania zawierający pochodne epotilonu | |
| IL174647A0 (en) | Pyrazolopyridines and analogs thereof | |
| IL163863A0 (en) | Form of presentation for3-Ä(2-äÄ4-(hexyloxycarbonylamino-imino-methyl)-phenylaminoÜmethylü-1-methyl-1H-benzimidaz | |
| PT1610784T (pt) | Formas de 5-azacitidina | |
| AU2002360487A8 (en) | Acyclovir-peptide analogs | |
| TWI318214B (en) | Somatosatin-dopamine chimeric analogs | |
| EP1610759A4 (en) | SUBSTITUTED QUINOBENZOXAZINE ANALOGUES | |
| EP1583549A4 (en) | YY PEPTIDE ANALOGS | |
| AP1955A (en) | Novel crystalline modification of the anhydrate ofboscalid | |
| IL158486A0 (en) | Nociceptin analogs | |
| GB0202900D0 (en) | Novel formulations of drugs | |
| IL165691A0 (en) | Epimerization of analogs of vitamin D | |
| EP1572950A4 (en) | SINGLE-DOMAIN-TDF-RELATED CONNECTIONS AND ANALOGS OF IT | |
| IL163696A0 (en) | Hfa-suspension formulation of an anhydrate | |
| AU2003298725A8 (en) | Preparation of metallotexaphyrins | |
| SI2264049T1 (sl) | Analogi 1-desamino-8-d-arginil vasopressina | |
| AU2003276752A8 (en) | Multiple domain tdf-related compounds and analogs thereof | |
| GB0328020D0 (en) | Silicon compounds | |
| GB0302079D0 (en) | Nematode containing formulation | |
| GB0317128D0 (en) | Use of antitumoral compounds | |
| GB0222015D0 (en) | Means of assembly-bozz 2 | |
| IL165356A0 (en) | Preparation of 4-haloalkylkylnicotinamides | |
| GB0201618D0 (en) | Silicon compounds | |
| TW503755U (en) | Improved structure of walking equipment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |